Part of a canonical cortical circuit is shown in the bottom left panel. The main panels (a, b) show the primary cellular and subcellular location(s) of the proteins encoded by schizophrenia susceptibility genes (purple on yellow) within the circuit. (a) An excitatory synaptic terminal (eg of a corticocortical pyramidal neuron, Schaffer collateral, or thalamic afferent), shown to the left in grey, contacts a dendritic spine of an intrinsic pyramidal neuron (grey, to its right). A dopaminergic afferent (blue-green) is shown terminating on the neck of the spine. A generic glial cell (green) is also shown apposed to the synapse. (b) An inhibitory interneuron (brown) is shown terminating on the dendritic shaft (or soma) of the pyramidal neuron. Note that not all genes may be expressed at the same time in the same cells. Minor locations for each protein have been omitted. The question mark denotes that the distribution of DISC1 is particularly unclear. In the case of NRG1 (blue), its main signalling pathways are included (solid arrows: direct actions; dashed arrows: downstream effects of ErbB activation) to illustrate the complexity of the interplay between the various cellular elements and the different susceptibility genes, which likely exists in vivo. Although this diagram emphasises location, the essential point is that the genes converge not upon any specific molecule or site but do so at the level of the plasticity and functioning of the microcircuitry. Variations in the genes affect schizophrenia risk by producing bottlenecks, that is, biasing the flux through specific molecular pathways, ultimately impairing optimal functioning of the circuits and the behaviours they subserve. So, for example: (1) COMT modulates cortical dopamine signalling via D1 receptors, which amplify NMDAR currents and are themselves recruited to the cell membrane by NMDAR signals; (2) NRG1 modulates NMDAR and GABAA receptor expression and recruits CHRNA7 receptors to synapses; (3) Dysbindin and PRODH regulate glutamate release; dysbindin is also involved in tethering GABAA and other receptors to the PSD and may be important in vesicular trafficking of presynaptic glutamate; (4) Calcineurin and Akt1 shape intracellular molecular pathways that are activated by excitatory inputs; (5) GRM3 interacts with NMDAR via modulation of glutamate release and glial reuptake, and so on. Additional abbreviations not defined in text: AMPAR, AMPA subtype of ionotropic glutamate receptor; DA, dopamine; D-Ser, D-serine; GAD, glutamic acid decarboxylase; Glu, glutamate; PSD, postsynaptic density. For more information on this topic, please see the article by Harrison and Weinberger on page 40-68.
